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The mechanisms that regulate the strength of synaptic transmission and intrinsic neuronal excitability are well 
characterized; however, the mechanisms that promote disease-causing neural network dysfunction are poorly 
defined. We generated mice with targeted neuron type–specific expression of a gain-of-function variant of the 
neurotransmitter receptor for glycine (GlyR) that is found in hippocampectomies from patients with temporal 
lobe epilepsy. In this mouse model, targeted expression of gain-of-function GlyR in terminals of glutamatergic 
cells or in parvalbumin-positive interneurons persistently altered neural network excitability. The increased 
network excitability associated with gain-of-function GlyR expression in glutamatergic neurons resulted in 
recurrent epileptiform discharge, which provoked cognitive dysfunction and memory deficits without affect-
ing bidirectional synaptic plasticity. In contrast, decreased network excitability due to gain-of-function GlyR 
expression in parvalbumin-positive interneurons resulted in an anxiety phenotype, but did not affect cognitive 
performance or discriminative associative memory. Our animal model unveils neuron type–specific effects 
on cognition, formation of discriminative associative memory, and emotional behavior in vivo. Furthermore, 
our data identify a presynaptic disease–causing molecular mechanism that impairs homeostatic regulation of 
neural network excitability and triggers neuropsychiatric symptoms.
Introduction
Research has established a solid basis for our understanding of how 
different nerve cells interact, assemble into functional units, and 
influence behavior and mood (1–4). High-frequency oscillation of 
the neuronal membrane potential creates permissive time windows 
for induction of sensory context–dependent bidirectional plasticity 
of glutamatergic synaptic transmission (1, 5, 6), which is a synaptic 
correlate of discriminative associative memory (6–9). Thus, temporal 
precision of neuronal inputs relative to the actual membrane poten-
tial is an important determinant of information coding and memory 
formation (5, 10–12). GABAergic synaptic transmission is equally 
relevant for cognitive function, because GABAergic interneurons 
regulate neuronal excitability and provide a spatiotemporal control 
framework for the timing of synaptic glutamatergic transmission. 
Fast-spiking (parvalbumin-positive) interneurons, for example, regu-
late hippocampal neural network oscillation in cognitively relevant 
high–gamma frequency ranges (13, 14). In conjunction with other 
interneuron types, they form a precision clockwork without which 
cortical operations are not possible (15, 16). Thus, spatiotemporal 
coordination of glutamatergic and GABAergic synaptic transmission 
is essential for sensory processing and cognitive performance.
Homeostatic plasticity in the somatodendritic neuronal com-
partment is known to regulate synaptic strength in order to keep 
the neuronal gain within physiological limits (17, 18). Nonetheless, 
impaired neural network homeostasis is associated with a pleth-
ora of clinical symptoms of neuropsychiatric disorders (1, 19–21) 
including cognitive dysfunction and various symptoms of mood 
disorders in patients with epilepsy (22, 23), which raises the ques-
tion of identifying the responsible molecular and cellular mecha-
nisms that are able to subvert homeostatic control of synaptic 
transmission and neural network excitability in disease conditions.
Glycine receptor (GlyR) α3 is a pathogenic molecular candidate, 
because changes in RNA processing of this subunit are associated 
with the pathophysiology of epilepsy (24–26). In fact, expression 
of RNA-edited GlyR α3 is increased in patients with temporal 
lobe epilepsy and leads to P185L amino acid substitution and neu-
rotransmitter receptor gain of function. Furthermore, it has been 
established that the RNA-spliced long GlyR α3L variant is prepon-
derantly expressed in the hippocampus of patients with epilepsy 
and shows particular synaptic clustering and physiological receptor 
properties (27, 28). To address the question of whether α3L185L-GlyR 
triggers clinical symptoms of epilepsy, we generated a correspond-
ing knockin mouse model and investigated the neuron type–specific 
functional impact of this particular molecule on bidirectional syn-
aptic plasticity, network excitability and gamma oscillatory activity, 
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cognitive function, discriminative associative memory, and mood-
related behavior. We show that the L-splice insert in GlyR α3L inter-
acts with SEC8, a member of the exocyst protein family of vesicular 
trafficking factors, and equips spliced α3L GlyRs with axonal and 
presynaptic trafficking signals. We observed that presynaptic GlyR 
α3L185L exerted an excitatory function by facilitating neurotransmit-
ter release, which increased the functional weight of neurons in the 
network. Functional enhancement of glutamatergic neurons elicit-
ed neural network hyperexcitability and recurrent epileptiform dis-
charge (large population of field excitatory postsynaptic potentials 
[EPSPs]), thereby impairing cognitively relevant gamma oscillatory 
network activity, cognitive function, and discriminative associative 
memory without influencing the bidirectional plasticity of gluta-
matergic synaptic transmission. Further, we found that functional 
enhancement of parvalbumin-positive interneurons reduced neural 
network excitability, impaired long-term depression of glutamater-
gic synaptic transmission, and triggered anxiety-related behavior 
without affecting cognitive function or memory formation. Thus, 
increased presynaptic function is a pathogenic disease mechanism, 
as it is able to subvert homeostatic control of synaptic transmission 
and neural network excitability, persistently affect neural network 
homeostasis, and trigger neuropsychiatric symptoms reminiscent 
of the epilepsy psychopathology.
Results
RNA splicing regulates axonal expression of GlyR α3. Hippocampal 
GlyRs are implicated in the regulation of glutamatergic synaptic 
transmission (27, 29). Here, we focused on the long (L) RNA splice 
variant of GlyR α3 because of its preponderance in brain (27). 
Unlike the short GlyR α3K variant, GlyR α3L contains exon 8A 
(30, 31), which codes for the TEAFALEKFYRFSDT peptide located 
in the large cytoplasmic loop between transmembrane domains 
3 and 4 (TM3-4). Exon 8A was shown to confer particular subcel-
lular trafficking and clustering properties on GlyR α3 (27, 28). 
To further investigate the relevance of this exon, we searched for 
interaction partners of GlyR α3L. To this end, the glutathione 
S-transferase–tagged (GST-tagged) α3L TM3-4 loop was used for 
cosedimentation assays with adult mouse brain lysate and mass 
spectrometric fingerprint analysis (Figure 1A and Supplemental 
Table 1; supplemental material available online with this article; 
doi:10.1172/JCI71472DS1). Our approach identified the vesicular 
trafficking factor SEC8 as a putative determinant of subcellular 
GlyR α3L localization (Supplemental Table 1, Exoc4). In fact, SEC8 
belongs to the exocyst complex protein family of vesicular traffick-
ing factors and was shown to be involved in targeting membrane 
material to presynaptic sites (32), as with glycine transporter GlyT1 
targeting to presynaptic glutamatergic terminals (33, 34). To cor-
roborate that the α3L TM3-4 loop interacts with SEC8, we probed 
the adult mouse brain proteins that cosedimented with GST::α3L 
or GST::α3K for SEC8 immunoreactivity (Figure 1B and full uncut 
gels are shown in the Supplemental Material). Indeed, our Western 
blot analysis with a SEC8 antibody confirmed cosedimentation of 
SEC8 with the TM3-4 loop of the GlyR α3L RNA splice variant 
(Figure 1B), while the α3K TM3-4 loop without exon 8A was far less 
effective. Thus, the peptide TEAFALEKFYRFSDT encoded by exon 
8A of the Glra3 gene facilitates interaction of GlyR α3 with SEC8.
Figure 1
The vesicular trafficking factor SEC8 is a 
new interaction partner of GlyR α3L and 
allows axonal receptor expression. (A) 
Proteins interacting with GST::α3L in the 
presence of adult mouse brain lysate were 
excised and analyzed with mass spectrom-
etry. Supplemental Table 1 provides a list 
of significant hits. (B) Western blot with an 
SEC8 antibody confirms the cosedimenta-
tion of SEC8 with GlyR α3L and identifies 
the spliced exon 8A coding for TEAFALE-
KFYRFSDT of GlyR α3L as the SEC8 
interaction domain. Equal GST bead load-
ing with α3K- or α3L-loops was verified 
with Coomassie staining (B, left panel). 
(C) SEC8 bound with the GlyR α3L TM3-4 
loop in HEK293 cells. The GlyR α3 TM3-4 
loop harbored an intrinsic NLS, which led 
to the translocation of SEC8::EGFP to the 
nucleus of HEK293 cells upon coexpression 
of the α3L-loop. (D–G) To investigate the role 
of SEC8 in subcellular GlyR α3L trafficking, 
primary hippocampal neurons were cotrans-
fected with HA-tagged full-length GlyR α3L 
and SEC8::EGFP or EGFP. Arrows indicate 
the presumptive axonal compartment devoid 
of MAP2, and arrowheads point to the 
somatodendritic MAP2-positive compart-
ment. Note that SEC8::EGFP coclustered 
with GlyR α3L in the MAP2-negative com-
partment, an activity that was not observed 
upon coexpression of EGFP. Scale bars: 
10 μm (C), and 5 μm (D–G).
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To verify the biochemical data, we tested for the interaction 
of α3K/L TM3-4 loops with SEC8 in a cellular context. For 
this purpose, we cotransfected human embryonic kidney 293 
(HEK293) cells with DsRed-Express–tagged α3K or α3L TM3-4 
loops and EGFP-tagged SEC8 (Figure 1C and Supplemental Fig-
ures 1–3). We performed quantification of nuclear versus cyto-
plasmic fluorescence and analysis of colocalization of α3 loops 
and SEC8::EGFP in the nucleus using fluorescence intensity 
measurements within circular regions of interest and line scans 
(Supplemental Figure 2 and Table 1). The fact that α3 loops 
harbor an effective nuclear localization sequence (NLS) (ref. 35, 
Supplemental Figure 2A, and Table 1) was particularly useful, 
because coexpression of the DsRed-E–tagged GlyR α3L, not 
α3K, loop increased the ratio between nuclear and cytoplasmic 
SEC8::EGFP fluorescence (Supplemental Figure 2A and Table 1) 
and revealed α3L loop–dependent translocation of SEC8::EGFP 
to the nucleus. In agreement with the α3L loop–dependent 
change in the nuclear gray level ratio between integrated DsRed-E 
and EGFP fluorescence intensities (Table 1), line scans of 
nuclear fluorescence profiles and pixel-wise correlation analysis 
further revealed an almost perfect overlap of SEC8::EGFP and 
α3L-NLS::DsRed-E, but not α3K-NLS::DsRed-E (Supplemen-
tal Figure 2B, C). Taken together with the observation that 
SEC8::EGFP expressed alone was not able to access the nucleus 
of HEK293 cells even when it was equipped with different NLSs 
(Supplemental Figures 1–3 and Table 1), these results demon-
strate that the RNA splicing–dependent L insert TEAFALEK-
FYRFSDT was responsible for nuclear SEC8 translocation.
Furthermore, we wanted to know whether SEC8 also influences 
subcellular trafficking of full-length GlyR α3L in neurons. There-
fore, we coexpressed SEC8::EGFP and HA-tagged full-length GlyR 
α3L (27) in primary hippocampal neurons. Figure 1, D and E, 
shows that GlyR HA-α3L accessed the presumptive axonal com-
partment (devoid of microtubule-associated protein 2 [MAP2]) 
when SEC8::EGFP was coexpressed, whereas GlyR HA-α3L clus-
ters were retained in the MAP2-positive somatodendritic compart-
ment when EGFP was coexpressed (Figure 1, F and G; arrowheads). 
GlyR HA-α3L clusters colocalized with SEC8::EGFP in MAP2-
negative neuronal processes (Figure 1, D and E; arrows). To verify 
axonal trafficking of HA-α3L upon coexpression of SEC8::EGFP, 
we used neurofilament M to stain the axonal compartment (Sup-
plemental Figure 4, A and B). Colocalized clusters of HA-α3L 
and SEC8::EGFP decorated the axonal arbor in 85.2% (23 of 27) 
of SEC8::EGFP-positive neurons, whereas a minor fraction (7.7%, 
2 of 26) of EGFP-coexpressing neurons showed axonal trafficking 
of HA-α3L. Quantification of GlyR HA-α3L immunofluorescence 
using line scans in cytoplasmic, dendritic, and neurofilament M–
positive axonal compartments revealed a significant SEC8::EGFP-
dependent increase in axonal GlyR α3L expression (Table 2, axon/
soma and axon/dendrite ratios). Pixel-wise correlation analysis 
of HA-α3L and SEC8::EGFP signal intensities further revealed a 
strong positive correlation between HA-α3L immunofluorescence 
and SEC8::EGFP fluorescence in axons (Supplemental Figure 4, B 
and C), which confirmed colocalization of both proteins. We found 
that a large number of colocalized, large (>1 μm in diameter) axonal 
GlyR HA-α3L and SEC8::EGFP clusters were associated with the 
Table 1
Summary of the quantification of integrated fluorescence intensities measured within circular (5 μm in diameter) regions of interest that 
were nucleus centered or positioned in the perinuclear cytoplasmic compartment of transfected HEK293 cells
 DsRed-E gray level ratio  EGFP gray level ratio  Nuclear gray level ratio 
 (nucleus/cytoplasm) (nucleus/cytoplasm) (DsRed-E/EGFP)
α3K-NLS::DsRed-E 7.32 ± 0.83 (n = 40) ND ND
α3L-NLS::DsRed-E 7.02 ± 0.56 (n = 40) ND ND
α3K-NLS::DsRed-E SEC8::EGFP 7.55 ± 0.69 (n = 50) 0.45 ± 0.03 (n = 50) 5.90 ± 0.35 (n = 50)
α3L-NLS::DsRed-E SEC8::EGFP 6.89 ± 0.41 (n = 46) 1.98 ± 0.17 (n = 46)A 1.24 ± 0.04 (n = 46)A
SEC8::EGFP ND 0.56 ± 0.03 (n = 43) ND
NLS-SEC8::EGFP ND 0.45 ± 0.05 (n = 39) ND
NLSα3_1-SEC8::EGFP ND 0.40 ± 0.10 (n = 36) ND
NLSα3_2-SEC8::EGFP ND 0.49 ± 0.05 (n = 40) ND
Note that only the α3L-NLS::DsRed-E loop significantly increased the SEC8::EGFP gray level ratio between nucleus and cytoplasm. Also note the signifi-
cant difference in gray level ratios (DsRed-E/EGFP) in α3L-NLS::DsRed-E/SEC8::EGFP- versus α3K-NLS::DsRed-E/SEC8::EGFP-coexpressing cells.  
AP < 0.001. Data represent the means ± SEM. ND, not determined.
Table 2
Summary of the quantification of integrated fluorescence intensities measured with line scans (10 μm in length) in axons, dendrites, and 
somata of transfected primary hippocampal neurons
 HA-α3L gray level ratio  HA-α3L gray level ratio HA-α3L gray level ratio 
 (axon/soma) (axon/dendrite) (dendrite/soma)
HA-α3L EGFP 0.17 ± 0.02 (n = 26) 0.23 ± 0.04 (n = 26) 0.83 ± 0.07 (n = 26)
HA-α3L SEC8::EGFP 0.84 ± 0.07 (n = 27)A 1.01 ± 0.11 (n = 27)A 0.91 ± 0.08 (n = 27)
Values represent calculated ratios between integrated HA-α3L pixel intensities in axon and soma, axon and dendrite, or dendrite and soma. Coexpression 
of SEC8::EGFP and GlyR HA-α3L significantly increased the ratios of integrated HA-α3L signal intensities between axon and soma as well as between 
axon and dendrite. AP < 0.001. Data represent the means ± SEM.
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vesicular glutamate transporter VGluT (185 of 215 clusters in 23 
of 27 SEC8::EGFP-coexpressing neurons, Supplemental Figure 4B, 
arrows), a vesicular axonal and presynaptic marker of glutamatergic 
neurons, whereas only some smaller axonal GlyR HA-α3L clusters 
in the EGFP-coexpressing neurons (2 of 26) colocalized with VGluT 
(5 of 24). Collectively, these results demonstrate that SEC8::EGFP 
facilitates axonal trafficking of HA-tagged GlyR α3L, and they 
suggest that SEC8 tethers GlyR α3L and VGluT in axonal cargo 
vesicles on their way to presynaptic terminals.
RNA editing leads to spontaneous channel opening of GlyR α3L. RNA 
editing of GlyR α3–coding mRNA leads to gain of function (26). 
In fact, substitution of the proline residue by the aliphatic hydro-
phobic amino acid leucine at position 185 in the mature GlyR 
α3 polypeptide impacts the conformation of the ligand binding 
domain and thereby confers increased accessibility of the neu-
rotransmitters glycine and GABA to the agonist binding site (24). 
Due to the close proximity of the RNA-edited position to the plas-
ma membrane, thermodynamic rules also imply a spontaneous 
channel opening of RNA-edited GlyR α3L185L in the absence of 
an agonist. We investigated this possibility by electrophysiological 
comparison of non–RNA-edited α3L185P and RNA-edited α3L185L 
in transfected HEK293 cells (Figure 2). The currents recorded in 
the absence of added glycine reflected agonist-independent chan-
nel opening of RNA-edited GlyR α3L185L (Figure 2A, red trace), 
while corresponding currents of the nonedited GlyR α3L185P had 
a much smaller amplitude (Figure 2A, black trace, and Figure 2C). 
Moreover, a commonly used concentration (1 μM) of the well-
known competitive GlyR antagonist strychnine was not able to 
fully block agonist-independent channel opening of RNA-edited 
GlyR α3L185L (Figure 2B, top red trace, and Figure 2C). A high 
concentration of strychnine (10 μM) was required to fully block 
this type of GlyR α3L activity in the nominal absence of glycine 
(Figure 2B, bottom red trace, and Figure 2C). This strychnine con-
Figure 2
GlyR α3L185L activation in the nominal absence of glycine. (A) Rep-
resentative recording traces of α3L185P- and α3L185L-dependent chlo-
ride currents in the nominal absence of glycine (driving force: 50 mV). 
(B) Representative traces show effects of increasing strychnine con-
centrations on agonist-independent GlyR α3L activity. (C) Quantifica-
tion of the effects of 1 μM and 10 μM strychnine on basal currents 
in HEK293 cells expressing either GlyR α3L185P (black bars) or GlyR 
α3L185L (red bars). Values represent the difference between the basal 
currents in the presence and absence of strychnine (1 μM or 10 μM). 
Traces shown in A and B belong to continuous recordings. Numbers of 
investigated cells are provided in parentheses. Note that a high dose of 
strychnine was required to fully block spontaneous GlyR α3L185L activ-
ity. Strychnine effects were fully reversible upon washout (not shown). 
Data represent the means ± SEM. **P < 0.01; ***P < 0.001.
Figure 3
Ultrastructural evidence for presynaptic GlyR α3L185L expression at 
hippocampal glutamatergic synapses. (A) Electron micrograph shows 
the distribution of HA-tagged GlyR α3L185L (peroxidase reaction end-
product) in VGluT1-positive boutons (b, immunogold particles) that 
established asymmetrical glutamatergic synapses with dendritic spines 
(s) and occasionally with dendritic shafts (den) in the stratum radia-
tum of the CA1 area. (B) Quantification of the percentage fractions of 
colocalized immunoreactivities. Using peroxidase staining of HA-GlyR 
α3L185L, the mean percentages (± SEM) of double-labeled (VGluT1/HA), 
α3L185L-positive (HA), VGluT1-positive, and nonlabeled terminals were 
determined in the inner molecular layer of the dentate gyrus (DG), the 
stratum radiatum of CA1 (CA1), and the stratum lucidum of CA3 (CA3). 
(C and D) To reveal the membrane topology of GlyR α3L185L, immuno-
reactivity for the receptor subunit was examined using immunogold 
labeling. Particles were mainly located on the luminal side of the gluta-
matergic vesicles (C), and occasionally inside the synaptic cleft (C and D, 
arrows). Scale bars: 200 nm.
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centration also blocks GABA type A receptors (GABAARs) (36) 
and, hence, is not suitable for the discrimination of glycine and 
GABA effects on neuronal function in slice preparations.
Knockin mouse model for characterization of GlyR α3L185L function in the 
brain. In order to investigate the functional role of GlyR α3L in vivo, 
we generated a knockin mouse line for Cre-dependent neuron type–
specific expression of the gain-of-function α3L receptor variant. For 
this purpose, we used a targeting vector containing the cDNA copy 
of the HA-tagged GlyR α3L185L RNA variant (ref. 24 and Supple-
mental Figure 5) for recombination with the X chromosomal Hprt 
gene locus. Cre recombinase–dependent excision of the floxed STOP 
cassette upstream of the DNA coding for HA-tagged GlyR α3L185L 
enables minigene protein expression in different neuron types.
Endogenous GlyR α3 is expressed in principal cells in stratum 
granulosum (27) and stratum pyramidale (37) as well as in fast-
spiking interneurons (Supplemental Figure 6). Therefore, we 
studied the functional impact of GlyR α3L185L on the two cog-
nitively relevant neuron types (principal cells and fast-spiking 
interneurons) by mating homozygous Hprtα3L185L+/+ females with 
heterozygous Camk2aCre+/– males (38) or homozygous PvalbCre+/+ 
males (39), which excises the STOP cassette and induces neuron 
type–specific GlyR α3L185L protein expression in principal cells or 
parvalbumin-positive neurons, respectively. Western blot analyses 
with an HA epitope–directed antibody indeed confirmed full-
length (48 kDa) HA-α3L185L GlyR expression in the hippocam-
pus and cortex of male offspring that were hemizygous for the 
HA-α3L185L allele (Hprtα3L185L+/0) and heterozygous for the Camk2aCre 
or PvalbCre alleles (Supplemental Figure 7). Male Hprtα3L185L+/0 mice 
were used as control animals. We also verified at a functional level 
that Cre recombinase induced gain-of-function GlyR α3L185L pro-
tein expression. For this purpose, Cre recombinase was expressed 
in primary neuron cultures of Hprtα3L185L+/0;Hprtα3L185L+/+ mice, and 
whole cell patch clamp recording was performed. Cre-positive neu-
rons indeed responded with transmembrane chloride currents to 
the application of a low (10 μM) glycine concentration (Supple-
Figure 4
Presynaptic GlyR α3L185L expression facilitates neurotransmitter 
release. (A) Sample traces of evoked glutamatergic postsynaptic cur-
rents recorded in response to repetitive stimulation of Schaffer col-
laterals with two pulses separated by a 50-ms interstimulus interval in 
Hprtα3L185L+/0 (black) and Hprtα3L185L+/0;Camk2aCre+/– (red) mice. Traces 
show responses normalized to the first pulse. (B) Quantification of 
paired-pulse ratios measured between responses of the second pulse 
to the first pulse. Note that the paired-pulse ratio was significantly 
decreased in Hprtα3L185L+/0;Camk2aCre+/– mice compared with that in 
control animals, indicating increased synaptic glutamate release in 
animals with presynaptic GlyR α3L185L expression in principal cells. 
Also note that acute strychnine application was able to level the differ-
ences between genotypes. **P = 0.0033; ***P = 0.0001. Data repre-
sent the means ± SEM.
Figure 5
Perisomatic inhibition is increased in mice with presynaptic 
GlyR α3L185L at GABAergic synapses of parvalbumin-pos-
itive interneurons. (A and B) Sample traces of evoked glu-
tamatergic field potentials (stimulation intensity: 0.03 mA) 
recorded in area CA1 of control animals (Hprtα3L185L+/0) and 
mice with GlyR α3L185L expression in parvalbumin-positive 
interneurons (Hprtα3L185L+/0;PvalbCre+/–). (C and D) Quanti-
fication of the relation between stimulation intensity and 
fiber volley (FV) (C) or amplitude of field potentials record-
ed upon Schaffer collateral stimulation (D). Note that ampli-
tudes recorded in slices from Hprtα3L185L+/0;PvalbCre+/– mice 
were significantly decreased upon stimulation at different 
intensities. *P < 0.05. Data represent the means ± SEM.
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mental Figure 8), which confirmed Cre-dependent excision of the 
floxed STOP cassette and, hence, induction of gain-of-function 
GlyR α3L185L protein expression.
Anatomical evidence for presynaptic GlyR α3L185L expression in vivo. 
We determined the characteristics of HA-α3L185L GlyR expression 
in principal glutamatergic neurons (Hprtα3L185L+/0;Camk2aCre+/–) 
using pre-embedding double immunochemistry and ultrastructur-
al analysis with electron microscopy. In Hprtα3L185L+/0;Camk2aCre+/– 
animals, HA-α3L185L immunoreactivity was found predominantly 
at VGluT1-positive glutamatergic terminals (Figure 3A), estab-
lishing asymmetrical synapses with dendritic shafts and pre-
dominantly with dendritic spines of putative principal cells in the 
inner molecular layer of the dentate gyrus (n = 341 terminals in 
2 animals), as well as in the stratum radiatum of cornu ammo-
nis subfield 1 (CA1) (n = 391) and in the stratum lucidum of CA3 
(n = 242). Approximately 40% of the VGluT1-positive presynap-
tic boutons (immunogold particles) showed immunoreactivity 
against HA-α3L185L (peroxidase reaction end product) in these 
areas, whereas 30%–45% of the 
terminals were immunopositive 
for the glutamate transporter, 
but not for the receptor pro-
tein (Figure 3B). In addition, we 
found a small subpopulation 
of axon terminals (3.6%) mak-
ing asymmetrical synapses with 
postsynaptic dendritic spines 
to be immunopositive for 
HA-3L185L, but not for VGluT1 
in the dentate gyrus (Figure 3B). 
Thus, GlyR HA-α3L185L spe-
cifically targets a subset of 
glutamatergic presynaptic terminals in mice with Camk2aCre-
dependent GlyR HA-α3L185L expression. In another set of experi-
ments, we identified VGluT1-positive terminals by the peroxidase 
reaction end product, and we detected immunoreactivity against 
HA-α3L185L with gold particles that allowed us to precisely visual-
ize the location of the receptor protein at presynaptic terminals 
(Figure 3, C and D). Immunogold particle labeling of HA-α3L185L 
revealed that the receptor protein was preferentially located over 
presynaptic vesicles (Figure 3, C and D). We found that approxi-
mately one-third of the immunoparticles in the investigated 
boutons were associated with synaptic or extrasynaptic terminal 
membranes (Figure 3, C and D, arrows; percentage of immuno-
gold particles in the dentate gyrus: 34.9 ± 7.3, CA3: 22.4 ± 1.5, CA1: 
33.1 ± 8.6; means ± SD). Thus, the ultrastructural analysis is con-
sistent with the proposed membrane topology of GlyRs, and it 
corroborates presynaptic GlyR α3L expression at glutamater-
gic synapses in vivo. We detected no immunoreactivity against 
HA-α3L185L in tissues obtained from control mice (Hprtα3L185L+/0).
Figure 6
Increased network excitability in Hprtα3L185L+/0; 
Camk2aCre+/– mice. (A) Sample traces of oscillatory 
network activity recorded in CA3. Power spectra of 
kainate-induced gamma oscillation in slices from 
control Hprtα3L185L+/0 and Hprtα3L185L+/0;Camk2aCre+/– 
mice exhibited a clear peak at 40 Hz. However, 
the power of gamma oscillation was significantly 
reduced in slices from all animals with targeted GlyR 
α3L185L protein expression (see Table 3 for details). 
(B and C) Recurrent epileptiform discharge (RED) 
occurred earlier following application of the GABAAR 
antagonist BIC (2.5 μM) in slices from Hprtα3L185L+/0; 
Camk2aCre+/– animals. (D) Hprtα3L185L+/0;Camk2aCre+/– 
animals also showed more severe seizures upon i.p. 
kainate injection than did Hprtα3L185L+/0 control mice. 
Racine score: stage 0, normal behavior; stage 1, 
chewing and facial movements; stage 2, head nod-
ding; stage 3, forelimb clonus; stage 4, rearing; stage 
5, rearing, falling, and loss of posture. Data repre-
sent the means ± SEM. *P < 0.05; **P < 0.01.
Table 3
Properties of gamma oscillations in hippocampal subfields CA1 and CA3
 Area Frequency (Hz) Amplitude (power, mV2/Hz)
Hprtα3L185L+/0 CA1 40.9 ± 4.798 Hz (n = 33) 1.01 ± 1.91 × 10–3 (n = 33)
 CA3 39.7 ± 4.192 Hz (n = 23) 1.18 ± 3.01 × 10–3 (n = 23)
Hprtα3L185L+/0;Camk2aCre+/– CA1 42.9 ± 9.711 Hz (n = 17) 0.20 ± 0.38 × 10–3 (n = 17)A
 CA3 42.6 ± 7.005 Hz (n = 18) 0.21 ± 0.56 × 10–3 (n = 18)
Hprtα3L185L+/0;PvalbCre+/– CA1 41.59 ± 5,723 Hz (n = 18) 0.13 ± 0.12 × 10–3 (n = 18)A
 CA3 40.48 ± 6,075 Hz (n = 23) 1.24 ± 2.49 × 10–3 (n = 23)
Amplitudes of gamma oscillations in CA1 were significantly different between mice with GlyR α3L185L protein 
expression and control animals (Hprtα3L185L+/0). AP < 0.05. Data represent the means ± SEM.
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To characterize subcellular HA-α3L185L trafficking in parval-
bumin-positive interneurons, we evaluated HA immunoreactivity 
in slice preparations from Hprtα3L185L+/0;PvalbCre+/– mice using con-
focal laser scanning microscopy, image deconvolution, and 3D 
reconstruction of multichannel images acquired in the stratum 
pyramidale. Quantification of colocalization between HA-α3L185L 
and parvalbumin using well-established Pearson’s correlation 
and Manders’ overlap coefficients (40) clearly revealed that GlyR 
HA-α3L185L overlapped with parvalbumin (Supplemental Fig-
ure 9; Pearson’s coefficient: 0.83 ± 0.01, Manders’ coefficient: 
0.964 ± 0.019; means ± SEM). More importantly, GlyR HA-α3L185L 
signals were also congruent with the vesicular inhibi-
tory amino acid transporter (VIAAT) (Supplemental 
Figure 9; Pearson’s correlation coefficient and Man-
ders’ overlap coefficient of colocalization between 
HA-α3L185L and VIAAT: 0.73 ± 0.03 and 0.953 ± 0.056, 
respectively; means ± SEM). VIAAT is a well-charac-
terized presynaptic marker of GABAergic synapses, 
hence, our high-resolution imaging approach dem-
onstrates presynaptic expression of HA-α3L185L-GlyRs 
at hippocampal parvalbumin-positive synapses. Col-
lectively, targeted expression of HA-α3L185L in our 
knockin mouse model led to presynaptic receptor 
localization in vivo.
Presynaptic GlyR α3L185L expression in vivo facilitates 
neurotransmitter release. To corroborate presynaptic 
GlyR α3L185L expression at a functional level, we 
performed a commonly used assay to determine 
the neurotransmitter release property of synapses. 
The paired-pulse recording approach examines the 
response properties of synapses during repetitive 
stimulation. By ruling out postsynaptic mecha-
nisms during two stimulations, this technique can 
provide information about the capacity of the pre-
synaptic neurotransmitter release machinery to satisfy repeti-
tive demands. A ratio of less than one between the second and 
first response indicates fatigue of this machinery (paired-pulse 
depression) and, hence, reflects a high probability of neurotrans-
mitter release upon the first stimulus. Likewise, a ratio greater 
than one (paired-pulse facilitation) indicates a low probability of 
transmitter release upon the first stimulus (41). To rule out con-
comitant recruitment of GABAergic synapses and their impact 
on glutamatergic synaptic transmission, we performed paired-
pulse recordings in the whole-cell configuration in the presence 
of gabazine (1 μM) and saclofen (100 μM), which block GABAARs 
Figure 7
Decreased network excitability in Hprtα3L185L+/0;PvalbCre+/– mice. (A and B) Comparison of the effects of different BIC concentrations (A, 2.5 μM; 
B, 10 μM) on the incidence of RED. (C) Quantification of the percentage of slices with epileptiform activity. Note that a high dose (10 μM) of the 
competitive GABAAR antagonist BIC was required to elicit epileptiform activity in Hprtα3L185L+/0;PvalbCre+/– mice.
Figure 8
Cell type–specific impairment of memory in GlyR α3L185L–expressing mice.  
(A) Quantification of errors made by animals of different genotypes in the 8-arm radial 
maze test. Working memory performance was determined according to the number 
of revisiting events during a fully baited 8-arm radial maze test. A high number of 
errors (working memory errors) indicated a poor working memory. (B) Quantification 
of errors made during analysis of reference memory. To this end, only 50% of the arms 
were baited, and the ability of animals to remember the arms that had food pellets 
was determined according to the number of visits to the nonbaited arms (reference 
memory errors). Data represent the means ± SEM. *P < 0.05; **P < 0.01; ***P < 0.001.
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and GABA type B receptors, respectively (Figure 4A). Camk2aCre-
dependent GlyR α3L185L protein expression began around post-
natal day 15 (Supplemental Figure 10), and whole-cell recordings 
performed at this age revealed that the paired-pulse ratio was 
significantly decreased in slices from Hprtα3L185L+/0;Camk2aCre+/– 
mice compared with those from control Hprtα3L185L+/0 animals 
(Figure 4B, 150.2 ± 10.8% vs. 253.2 ± 24.3%). Because spontane-
ous channel openings of GlyR α3L185L in the nominal absence 
of glycine necessitate a high dose of strychnine for full receptor 
antagonism (above, Figure 2), we used 10 μM strychnine here. 
We found that strychnine leveled the difference between geno-
types in paired-pulse recordings (Figure 4B, 226.7 ± 24.1% vs. 
225.7 ± 30.8%), confirming that the observed genotype-specific 
difference was due to targeted GlyR α3L185L expression. Thus, 
presynaptic GlyR α3L185L expression in Hprtα3L185L+/0;Camk2aCre+/– 
animals increased synaptic glutamate release.
Facilitation of presynaptic GABA release due to targeted GlyR 
α3L185L expression in parvalbumin-positive interneurons should 
increase perisomatic inhibition and hence affect glutamatergic 
synaptic transmission. To address this possibility, we recorded 
evoked field potentials in area CA1 in response to Schaffer col-
lateral stimulation in the absence of GABAAR antagonists 
(Figure 5, A and B). While volleys generated by glutamatergic fibers 
were not influenced by the genotype (Figure 5C), the amplitudes 
of field potentials were indeed significantly reduced in slices from 
Hprtα3L185L+/0;PvalbCre+/– animals (Figure 5D) . The chloride trans-
porter antagonist bumetanide (50 µM) minimized differences 
between genotypes (not shown). These results demonstrate that 
presynaptic GlyR α3L185L expression in parvalbumin-positive 
interneurons increases perisomatic inhibition.
Neuron type–specific GlyR α3L185L effects on network properties and 
excitability in vivo. To address the impact of enhanced neuronal 
function on a neural network substrate of cognitive function, 
we investigated high-frequency (gamma) oscillatory network 
activity in Hprtα3L185L+/0;Camk2aCre+/–, Hprtα3L185L+/0;PvalbCre+/–, and 
Hprtα3L185L+/0 control mice using local field potential recordings 
in hippocampal subfields CA1 and CA3. Gamma rhythm in the 
hippocampus could be induced in all three genotypes follow-
ing bath application of 400 nM kainate, as described previously 
(42). The power spectra of the oscillations in slices of the differ-
ent genotypes showed a clear peak in the 40-Hz frequency band 
(Figure 6A and Table 3). However, the power of gamma oscillations in 
the CA1 region was significantly reduced in slices from Hprtα3L185L+/0; 
Camk2aCre+/– and Hprtα3L185L+/0;PvalbCre+/– mice (Table 3). To assess 
hippocampal network excitability, the latency to recurrent epi-
leptiform discharge upon blockage of GABA-ergic inhibition 
with a low dose (2.5 μM) of the competitive GABAAR antagonist 
bicuculline methiodide (BIC) was measured first in Hprtα3L185L+/0; 
Camk2aCre+/– animals (Figure 6B). Network disinhibition with 2.5 μM 
BIC indeed induced epileptiform network activity (Figure 6B), 
and the latency to pathological activity was significantly shorter 
in slices from Hprtα3L185L+/0;Camk2aCre+/– mice compared with those 
from Hprtα3L185L+/0 mice (7.0 ± 1.0 minutes vs. 10.5 ± 1.1 minutes) 
(Figure 6C), which is in agreement with the facilitation of pre-
synaptic glutamate release due to targeted GlyR α3L185L expres-
sion (see Figure 4). Increased network excitability in Hprtα3L185L+/0; 
Camk2aCre+/– mice should also increase behavioral seizure activity. 
Therefore, we administered an i.p. injection of kainate and mea-
sured behavioral seizure activity according to the Racine classifi-
cation (Figure 6D). Behavioral seizures were indeed exacerbated 
Figure 9
Cell type–specific effects of GlyR α3L185L 
protein expression on bidirectional synap-
tic plasticity of glutamatergic transmission.  
(A and B) GlyR α3L185L–dependent effects on 
LTP and LTD. Normalized responses record-
ed in slices from the different genotypes are 
represented by color-coded symbols (black: 
Hprtα3L185L+/0, red: Hprtα3L185L+/0;Camk2aCre+/–, 
blue: Hprtα3L185L+/0;PvalbCre+/–). Note that GlyR 
α3L185L expression in PvalbCre-positive mice 
impaired expression of LTD. Also note that 
GlyR α3L185L expression did not affect the 
ratio between the magnitudes of LTP and LTD 
when expressed in Hprtα3L185L+/0;Camk2aCre+/– 
or Hprtα3L185L+/0 animals, whereas it reduced 
this ratio if expressed in Hprtα3L185L+/0; 
PvalbCre+/– animals (see Table 4 for values). 
(C and D) Quantification of strychnine effects 
on LTP and LTD. Strychnine leveled the dif-
ferences between genotypes in both LTP and 
LTD (see Table 4 for values). Data represent 
the means ± SEM.
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in Hprtα3L185L+/0;Camk2aCre+/– mice, and pronounced differences 
between the two genotypes were observed 50–60 minutes after the 
kainate injection (Figure 6D).
In contrast to Hprtα3L185L+/0;Camk2aCre+/– animals, Hprtα3L185L+/0; 
PvalbCre+/– mice required a higher dose (10 μM) of the competitive 
GAB AAR antagonist BIC to generate epileptiform discharge in 
slice preparations (Figure 7). Qualitatively, we obtained the same 
results with different concentrations of another competitive 
GABAAR antagonist, i.e., 0.3 μM and 3 μM gabazine (Supplemen-
tal Figure 11). Thus, consistent with the data from the field poten-
tial recordings (see Figure 5), presynaptic GlyR α3L185L expression 
at parvalbumin-positive GABAergic synapses decreased network 
excitability. Collectively, these results demonstrate that GlyR 
α3L185L persistently increased neuronal impact in the neural net-
work through a presynaptic mode of action in glutamatergic prin-
cipal cells and parvalbumin-positive interneurons.
Consequences of neuronal enhancement for synaptic plasticity and 
behavior in vivo. Bidirectional synaptic plasticity, in the form 
of long-term potentiation and depression (LTP and LTD), is 
deemed to be the cellular substrate for associative spatial mem-
ory (43–45). However, recent evidence also demonstrated that 
LTP at the Schaffer collateral synapse influences discrimina-
tion of competing or overlapping memories and corresponding 
behavioral responses. To determine whether neuronal enhance-
ment influences bidirectional plasticity of glutamatergic syn-
aptic transmission and its relation to performance in learning 
and memory tasks, we used the reward-based 8-arm radial maze 
test, which addresses discriminative associative memory forma-
tion, and compared short- (working) and long-term (reference) 
memory of mice with enhanced function of glutamatergic prin-
cipal cells or parvalbumin-positive interneurons (Figure 8, A and 
B). The learning curve in Figure 8A shows that working mem-
ory was impaired in Hprtα3L185L+/0;Camk2aCre+/– mice, since they 
required more trials than control Hprtα3L185L+/0 or Hprtα3L185L+/0; 
PvalbCre+/– animals. Furthermore, reference memory was selec-
tively impaired in Hprtα3L185L+/0;Camk2aCre+/– mice (Figure 8B). For 
control purposes, we verified that the genotype did not influence 
motor coordination or hedonic behavior (Supplemental Figure 
12). These results demonstrate that Hprtα3L185L+/0;Camk2aCre+/– 
mice were impaired in working memory formation and deficient 
in reference memory in a behavioral test that addressed discrimi-
native associative memory (46).
As LTP deficiency at the Schaffer collateral syn-
apse was shown to impair discriminative asso-
ciative learning (46), we expected Hprtα3L185L+/0; 
Camk2aCre+/– animals to be deficient in LTP. 
However, LTP could successfully be evoked by 
an appropriate stimulation protocol in all ani-
mal groups (Figure 9A and Table 4), while LTD 
could not be elicited specifically in Hprtα3L185L+/0;
PvalbCre+/– mice (Figure 9B and Table 4). Quanti-
tative analysis of bidirectional synaptic plastic-
ity (LTP/LTD ratio) furthermore revealed that 
bidirectional synaptic plasticity was compro-
mised in Hprtα3L185L+/0;PvalbCre+/– mice compared 
with Hprtα3L185L+/0;Camk2aCre+/– animals (Table 4). 
Thus, much to our surprise, Hprtα3L185L+/0;PvalbCre+/– 
mice performed normally in the discriminative 
associative learning and memory tests despite 
a reduced magnitude of bidirectional synap-
tic plasticity, whereas Hprtα3L185L+/0;Camk2aCre+/– mice did not — 
although their LTP/LTD ratio did not differ from that of control 
animals. For control purposes, we confirmed that strychnine lev-
eled the genotypic differences (Figure 9, C and D, and Table 4).
An alternative explanation for the impaired discriminative asso-
ciative learning of Hprtα3L185L+/0;Camk2aCre+/– mice is a failure of 
sensory context–dependent formation of small neuronal assem-
blies (1). Therefore, we revisited our data on hippocampal network 
oscillation in the gamma band and evaluated the characteristics of 
this type of cognitively relevant network activity on a longer time 
scale (Figure 10). We found that gamma oscillation was stable over 
a long period in Hprtα3L185L+/0 and Hprtα3L185L+/0;PvalbCre+/– animals 
(Figure 10, A and B). However, with increased network excitability, 
it was consistently disrupted by EPSPs in slices from Hprtα3L185L+/0; 
Camk2aCre+/– animals (Figure 10C). In fact, this type of pathological 
network activity disrupted gamma oscillations in the vast majority 
(11 of 13, 85%) of Hprtα3L185L+/0;Camk2aCre+/– mice. Consistently, we 
observed that cognitive performance was affected, as these animals 
were substantially impaired in their ability to discriminate familiar 
and novel objects during the novel object recognition task (Sup-
plemental Figure 12E). Thus, impaired cognitive function could 
underlie and explain poor performance in discriminative associative 
working and reference memory. On the other hand, Hprtα3L185L+/0; 
PvalbCre+/– mice performed as well as Hprtα3L185L+/0 control animals at 
the novel object recognition task, but they showed anxiety-related 
behavior in corresponding tests (Figure 11; light/dark preference, 
open field, and elevated plus maze tests). Hprtα3L185L+/0;PvalbCre+/– 
mice were indistinguishable from control animals with respect to 
motor coordination and locomotion (Supplemental Figure 12, 
A–C), ruling out motor skills impairment as a reason for their anx-
iety-related behavior. Collectively, these data identify a critical role 
for parvalbumin-positive interneurons in anxiety, and they demon-
strate that factors other than bidirectional synaptic plasticity can 
cause impairment of discriminative associative memory.
Discussion
This study advances our knowledge of neural network mecha-
nisms in the brain and their relation to cognitive dysfunction 
and emotional behavior in disease. Using a new animal model, we 
investigated the functional impact of the disease-relevant α3L185L-
GlyR RNA variant on bidirectional synaptic plasticity, network 
excitability, cognitive function, discriminative associative memo-
Table 4
Summary of the changes in EPSP slopes during recording of bidirectional synaptic 
plasticity
 Strychnine LTP LTD LTP/LTD ratio
Hprtα3L185L+/0  – 1.81 ± 0.05 0.86 ± 0.02 2.11 ± 0.09
 + 1.73 ± 0.06 0.86 ± 0.04 2.01 ± 0.29
Hprtα3L185L+/0;Camk2aCre+/– – 1.39 ± 0.06A 0.62 ± 0.05B 2.24 ± 0.18
 + 1.72 ± 0.04 0.85 ± 0.03 2.02 ± 0.09
Hprtα3L185L+/0;PvalbCre+/– – 1.72 ± 0.07 1.02 ± 0.05B 1.69 ± 0.14C
 + 1.71 ± 0.09 0.82 ± 0.05 2.08 ± 0.19
Values represent changes between averaged EPSP slopes after (time point “b” in Figure 9) 
and before (time point “a” in Figure 9) stimulation. AP < 0.01 and BP < 0.001 denote differences 
between mice with GlyR α3L185L protein expression and control animals (Hprtα3L185L+/0).  
CP < 0.05 denotes differences between Hprtα3L185L+/0;PvalbCre+/– and Hprtα3L185L+/0;Camk2aCre+/– 
animals. Data represent the means ± SEM.
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ry, and mood-related behavior. GlyR α3L185L was expressed at pre-
synaptic sites through its interaction with the vesicular traffick-
ing factor SEC8, which facilitated neurotransmitter release and 
increased the functional impact of neurons in the network. Mice 
with a hyperexcitable hippocampal circuitry due to GlyR α3L185L 
expression in glutamatergic presynaptic terminals showed cog-
nitive dysfunction and impairment of discriminative associative 
memory, whereas mice with functional enhancement of parval-
bumin-positive interneurons had a hypoexcitable hippocampal 
circuitry and showed impaired LTD of glutamatergic synaptic 
transmission as well as anxiety-related behavior without changes 
in cognitive function and memory formation. Our animal model 
unveils a neuron type–specific functional impact on cognition, 
formation of discriminative associative memory, and emotional 
behavior in vivo, and demonstrates that changes in presynaptic 
function impairs neural network homeostasis and triggers neuro-
psychiatric symptoms reminiscent of epilepsy psychopathology.
New animal model for the study of neuron type–specific effects on behavior. 
A cDNA minigene coding for a floxed allele of the disease-relevant 
RNA variant GlyR α3L185L (24–26) was recombined with the Hprt 
gene locus on the X chromosome and allowed neuron type–specif-
ic targeted (ectopic) gain-of-function receptor expression in hemi-
zygous males, i.e., in addition to Glra3 gene promoter–dependent 
GlyR α3 expression. Ectopic GlyR α3L185L expression has several 
advantages: (a) It more closely matches the situation in patients 
with epilepsy, because RNA-edited and nonedited GlyRs coex-
ist in neurons due to the enzymatic nature of RNA editing; (b) 
replacement of the Glra3 gene with the GlyR HA-3L185L knockin 
cassette would knock out Glra3 gene function, yield a fraction of 
total RNA–edited Glra3 mRNA, and considerably overrepresent 
GlyR α3L185L function; (c) Glra3 gene replacement with our cDNA 
copy of GlyR α3L185L would reflect Glra3 gene promoter regulation 
and preclude analysis of the spatiotemporal (neuron type–specific) 
effects of RNA-edited GlyR α3L, which depends on the regulation 
of neuronal C-to-U RNA-editing enzymes (47, 48).
The immunocytochemical experiments revealed that interaction 
of the L-splice insert TEAFALEKFYRFSDT with SEC8 facilitates 
axonal GlyR HA-α3L protein expression. Targeted presynaptic 
GlyR HA-α3L185L protein expression in vivo was confirmed using 
the HA epitope tag at the receptor N terminus (24, 27, 28) in 
immunohistochemical and ultrastructural analyses. Presynaptic 
GlyR expression is known to facilitate synaptic transmission due 
to a depolarized chloride reversal potential for axonal versus peri-
somatic ligand–gated chloride channels (49–53), and consistently, 
presynaptic GlyR HA-α3L185L influenced the paired-pulse ratio 
of postsynaptic currents and decreased the amplitude of evoked 
excitatory field potentials when expressed in glutamatergic or 
parvalbumin-positive neurons, respectively. This presynap-
tic mode of GlyR α3L185L action in vivo persistently enhanced 
neuronal function, affected neural network excitability in a neu-
ron type–specific way, and triggered neuropsychiatric symptoms 
reminiscent of the epilepsy psychopathology, all of which identify 
an antihomeostatic role for changes in presynaptic function.
Synaptic plasticity, cognitive function, and discriminative associa-
tive memory. Bidirectional synaptic plasticity (LTP and LTD) is 
a cellular substrate for discriminative associative memory (6–9, 
43–46). However, our study reveals that working and reference 
memory can be impaired even when bidirectional synaptic plastic-
ity works properly. In fact, the recurrent epileptiform discharge 
in hippocampal slices from Hprtα3L185L+/0;Camk2aCre+/– mice inter-
rupts the temporally ordered representation of sensory contexts 
in specific groups of neurons (ref. 1 and Figure 10, D and E) and 
interferes with context-dependent selection of synapses, which 
need to be potentiated or de-potentiated during memory forma-
tion. Consistently, Hprtα3L185L+/0;Camk2aCre+/– animals showed cog-
nitive deficits, since they were unable to distinguish between novel 
and familiar objects (Supplemental Figure 12E). Hence, the ability 
Figure 10
Recurrent epileptiform discharge disrupts gamma frequency net-
work oscillation. (A and B) Sample traces illustrating that the control 
Hprtα3L185L+/0 and Hprtα3L185L+/0;PvalbCre+/– animals displayed stable and 
regular gamma network oscillation. (C) Representative trace showing 
recurrent epileptiform discharge in Hprtα3L185L+/0;Camk2aCre +/– animals. 
Arrows indicate the characteristic depression of network activity follow-
ing pathological network activity. Also note that high-frequency ripple 
oscillatory activity preceded hypersynchronous neuronal discharge 
(band-pass filtered, 120-300 Hz, see Supplemental Figure 14). (D) 
Each peak during gamma network oscillation represents the activity of 
sensory context–dependent neuronal assemblies (black triangles). (E) 
Schematic illustrating the conflict of interest of neurons (red triangles) 
due to their participation in hypersynchronous network activity.
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of neural networks to effectuate regular gamma network oscilla-
tion is a prerequisite for the formation of discriminative associa-
tive memory, as it will help direct synaptic plasticity in a sensory 
context–dependent, spatiotemporally coordinated way.
Parvalbumin-positive interneurons and anxiety. Benzodiazepines 
were reported to have anxiolytic effects through the potentiation of 
GABAARs with the α2 subunit (16). As α2-GABAARs appear to be 
preferentially expressed at synapses formed by CCK-positive inter-
neurons, this type of interneuron is considered a cellular substrate 
for anxiety and mood disorders (4). Benzodiazepines also enhance 
the function of GABAARs with α1 and γ2 subunits (54–56), 
which were reported to be primarily associated with synapses 
formed by parvalbumin-positive interneurons (15, 16). Therefore, 
benzodiazepine action on this interneuron type is considered to 
mediate the sedative component of drug action (57). However, 
recent experiments showed that α1- and α2-containing GABAARs 
coexist in most of the perisomatic GABAergic synapses formed by 
CCK- and parvalbumin-positive interneurons (58). Thus, benzo-
diazepines may have a plethora of effects on behavior, since they 
target different types of interneurons. Our genetic approach iden-
tifies parvalbumin-positive interneurons as a critical cellular sub-
strate of anxiety. Furthermore, we found that LTD deficiency was 
associated with anxiety-related behavior of Hprtα3L185L+/0;PvalbCre+/– 
mice, which compares with the finding that molecular changes 
involving experience-driven brain-derived neurotrophic factor 
(BDNF) receptor TRKB signaling in the hippocampus contributes 
to anxiety in an animal model of epilepsy (59).
Implications for disease. Our recent studies established that 
hippocampal RNA editing of GlyR α2 and α3 generates gain-of-
function receptors and is coregulated in 53% of patients with tem-
poral lobe epilepsy, accounting for up to 50% of α2- and α3-coding 
GlyR mRNA (24–26). In the hippocampus of our knockin animals, 
74.9 ± 7.2%, 78.5 ± 3.7%, and 77.5 ± 13.2% of GlyR α3-coding tran-
scripts were edited in Hprtα3L185L+/0, Hprtα3L185L+/0;Camk2aCre+/–, and 
Hprtα3L185L+/0;PvalbCre+/– animals, respectively (Supplemental Fig-
ure 13). At first glance, these results indicate an overexpression of 
α3L185L mRNA relative to the fraction of RNA-edited α3 mRNA 
in patients (25). However, targeted expression of α3L185L mRNA 
is under the control of the ubiquitous chicken β-actin (Actb) 
promoter, and thus α3L185L-coding mRNA was expressed in all 
hippocampal cells including glia. Since the Glra3 promoter does 
not lead to GlyR α3 expression in glia (27, 60), quantification of 
the fraction of RNA-edited GlyR α3–coding mRNA in our animal 
model considerably overestimated the neuronal fraction of α3L185L-
coding mRNA. Furthermore, taking into account the coregulated 
expression of α2-  and α3-GlyRs in principal hippocampal neurons 
(29, 60) and fast-spiking interneurons (Supplemental Figure 6) as 
well as the fact that GlyR α2 and α3L fulfill a presynaptic task (ref. 29, 
and this study, respectively), GlyR α3L185L expression in our ani-
mal model functionally represents ensemble GlyR RNA editing in 
the hippocampus of patients with epilepsy. For these reasons, our 
animal model is suitable for investigation of the clinically relevant 
neuron type–specific effects of GlyR RNA editing in epilepsy.
The marked similarities between pathological hallmarks of net-
work activity in animal models (61) and patients (62) and the charac-
teristics of recurrent epileptiform discharge observed in Hprtα3L185L+/0; 
Camk2aCre+/– animals (Figure 10 and Supplemental Figure 14) sup-
port a pathogenic role for GlyR C-to-U RNA editing in principal 
neurons. In fact, members of the APOBEC family of C-to-U RNA-
editing enzymes are expressed in principal neurons and possibly also 
in interneurons (47, 48). Whether spatiotemporal regulation governs 
GlyR C-to-U RNA editing in vivo is presently unclear, but an interest-
ing possibility is that principal neurons and interneurons alternate in 
GlyR RNA editing and thereby contribute to alternating episodes of 
cognitive dysfunction during epileptic seizures and interictal anxiety, 
which is a well-known psychiatric comorbidity of epilepsy (ref. 63, 
and for a comprehensive review, see ref. 22). Experience-dependent 
effects certainly contribute to anxiety symptoms in patients with epi-
lepsy, and a recent study identified experience-driven BDNF receptor 
TRKB signaling in an animal model of epilepsy as a molecular sub-
strate of anxiety (59). Our study identifies a corresponding cellular 
substrate of anxiety and furthermore unveils a possible critical role 
for LTD deficiency in the expression of anxiety-related behavior.
In conclusion, increased presynaptic function of principal cells 
or interneurons impairs neural network homeostasis and trig-
gers neuropsychiatric symptoms that resemble the psychopa-
thology of epilepsy.
Methods
Targeted HA epitope–tagged GlyR α3L185L mice and Cre lines. The GlyR α3L185L 
knockin mouse was developed in 129/Ola (E14) ES cells, in which 35 kb 
of the Hprt gene encompassing the 5′ untranslated region (5′-UTR) up to 
Figure 11
Analysis of anxiety-related behavior. Data extracted from the different 
genotypes are represented by color-coded bars (black: Hprtα3L185L+/0, 
red: Hprtα3L185L+/0;Camk2aCre+/–, blue: Hprtα3L185L+/0;PvalbCre+/–). Only the 
Hprtα3L185L+/0;PvalbCre+/– mice exhibited anxiety-related behavior in light/
dark preference (A and B), open field (C and D), and elevated plus 
maze (E and F) tests, whereas Hprtα3L185L+/0;Camk2aCre+/– and con-
trol mice (Hprtα3L185L+/0) did not show differences. Data represent the 
means ± SEM. *P < 0.05; **P < 0.01; ***P < 0.001.
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intron 2 was deleted (Supplemental Figure 5). In the first phase of the proj-
ect, the targeting vector was constructed by inserting the CAG promoter 
(a combination of the cytomegalovirus early enhancer element and the 
chicken Actb promoter), the floxed STOP cassette and the HA-tagged GlyR 
α3L185L cDNA (24, 27) into a genOway Quick Knock-In targeting vector. 
Homologous recombination of the genOway targeting vector with the Hprt 
gene locus repairs the Hprt gene deletion (Supplemental Figure 5, Hprt-HR). 
During the ES cell phases, the reconstituted Hprt gene was selected using 
hypoxanthine, aminopterine, and thymidine (HAT) media to enrich for ES 
cell clones showing the correct targeting event. The construct was then elec-
troporated into 129/Ola (E14) ES cells, and the HAT-resistant ES cell clones 
were isolated. Chimeric males generated from the ES cell clones were mated 
with wild-type C57BL/6J females, and germline transmission to agouti F1 
females (B6;129P2-Hprt<tm1(CAG-Glra3*)GW>) was verified by Southern 
blotting (not shown). Heterozygous F1 females were bred with wild-type 
C57BL/6J males to generate F2 hemizygous males for inbreeding purposes.
To achieve GlyR α3L185L expression in glutamatergic principal neurons, 
homozygous B6;129P2-Hprt<tm1(CAG-Glra3*)GW/MEJ> females (abbre-
viated as Hprtα3L185L+/+) were crossed with heterozygous B6.FVB-Tg(Camk2a-
Cre)2Gsc/Cnrm (abbreviated as Camk2aCre+/–) males (provided by Günther 
Schütz, German Cancer Research Center DKFZ, Heidelberg, Germany). 
Male offspring (Hprtα3L185L+/0;CamkCre+/–) aged between 3 and 5 months 
that were hemizygous for the GlyR α3L185L allele and heterozygous for the 
Camk2aCre+/– allele were used. For receptor expression in parvalbumin-pos-
itive interneurons, homozygous Hprtα3L185L+/+ females were crossed with 
homozygous B6;129P2-Pvalb<tm1(Cre)Arbr>/J (abbreviated as PvalbCre+/+) 
males (The Jackson Laboratory), and 3- to 5-month-old male offspring 
(Hprtα3L185L+/0;PvalbCre+/–) were used. Age-matched Hprtα3L185L+/0 male mice 
were used as control animals. Genotyping was performed on genomic 
DNA obtained from tail biopsies. Genomic DNA was isolated using a stan-
dard protocol. Briefly, tail lysis was performed at 55°C for 1 to 2 hours in 
the presence of proteinase K (1 mg/ml) in a buffer containing 100 mM Tris 
(pH 8.0), 5 mM EDTA, 200 mM NaCl, and 0.2% SDS. RNA was degraded 
with 0.2 mg/ml RNase A for 15 minutes at 37°C. Following isopropanol 
precipitation, 10 ng of genomic DNA was used in combination with the 
oligonucleotides and PCR programs listed in Supplemental Table 2.
Targeted GlyR α3L185L expression did not affect the viability of the mice; 
survival rates of GlyR α3L185L–knockin animals (Hprtα3L185L+/0) and male off-
spring of the Hprtα3L185L+/0 mice mated with Camk2aCre+/– or PvalbCre+/+ animals 
were 97.4% (112 of 115), 96.2% (50 of 52), and 91.5% (54 of 59), respectively.
Molecular procedures. We thank Susanne Schoch (University of Bonn, 
Institute of Neuropathology, Bonn, Germany) for providing a human 
synapsin-1 promoter-containing clone and Sebastian Auer (Max Delbrück 
Center for Molecular Medicine, Berlin, Germany) for providing a Cre 
recombinase–encoding clone. Details on molecular cloning, constructs, 
quantification of the fraction of GlyR α3185L–coding mRNA, and single-
cell PCR are provided in the Supplemental Methods.
Preparation of mouse brain crude protein extract. Mouse brains were minced, 
transferred to buffer (0.1 M Tris pH 8.0, 0.3% Triton X-100, protease inhibi-
tor; Roche) and homogenized using a Potter S homogenizer (Sartorius). 
The crude protein extract was centrifuged, and the soluble supernatant was 
used for further experiments. Determination of protein concentration was 
performed using the Bradford assay (64).
Preparation of GST-tagged receptor loops. Immobilized GST and GST-
tagged α3 loops were prepared using E. coli (strain ER2566; New Eng-
land Biolabs Inc.). Transformed bacteria were grown to an OD600 of 0.7 
in lysogeny broth medium at 37°C. Then, they were cooled to 22°C and 
induced with 100 μM isopropyl-β-thiogalactosidase. Cells were harvested 
4 hours later and resuspended in PBS (pH 7.4) containing protease inhibi-
tor and 137 mM NaCl, 2.7 mM KH2PO4, 8.1 mM Na2HPO4, and 1.76 mM 
KCl. For protein solubilization, a cell disruptor was used, and the crude 
protein extract was centrifuged to obtain the clarified supernatant, which 
was loaded onto 400 μl glutathione sepharose 4 Fast Flow Beads (GE 
Healthcare). After incubation for 1.5 hours at 4°C under shaking, the sep-
harose beads with bound GST or GST-tagged receptor loops were washed 
with 30 column volumes of PBS. The prepared beads were stored at 4°C 
in PBS with additional protease inhibitor. Aliquots of the beads were ana-
lyzed via SDS-PAGE and stained with Coomassie brilliant blue to quantify 
their quality and loading capacity.
Cosedimentation (mass spectrometry). Depending on the receptor loop 
saturation, receptor loop beads (10–20 μl) were used for cosedimentation 
experiments. GST-loaded beads were used as a negative control. The dif-
ferent samples were incubated for 1.5 hours at room temperature under 
gentle shaking with 4 mg mouse brain crude extract in a total volume 
of 80 μl and pulldown buffer containing 20 mM Tris (pH 8.0), 150 mM 
NaCl, and 1 mM EDTA. Afterward, the beads were sedimented at 1,200 g 
for 4 minutes, and the supernatant was removed. In order to remove 
unbound proteins, the receptor loop beads were washed four times with 
1 ml wash buffer containing 20 mM Tris (pH 8.0), 50 mM NaCl, and 1 mM 
EDTA. Sepharose bead elution was performed with 10 mM glutathione 
dissolved in wash buffer. Elution and supernatant fractions (both 14 μl) 
were analyzed with SDS-PAGE and silver staining (G-Biosciences). As a 
negative control, identical amounts of coated beads were processed in the 
same manner without addition of brain crude extract. Protein bands in 
the GST::α3L GlyR sample, not in the GST sample, were excised and ana-
lyzed by peptide mass fingerprinting at the Centre for Molecular Medicine 
(Cologne, Germany). Data were processed using the Mascot Search Engine 
software (Matrix Science) (65).
Cosedimentation (SEC8 interaction). To study cosedimentation of α3K 
and α3L loops with SEC8, 600 μg crude brain extract was used. GST, 
GST::α3K, and GST::α3L loops including possibly interacting proteins 
were eluted from the sepharose beads with 10 mM glutathione. Samples 
were then subject to SDS-PAGE, Coomassie staining, and Western blot 
analysis. SEC8 was detected with a mouse monoclonal antibody against 
SEC8 (14G1, 1:1,000; Abcam) and anti-mouse alkaline phosphatase–cou-
pled antibody (1:3,000; Sigma-Aldrich).
Western blot analysis. Western blot analysis was also performed for verifica-
tion of GlyR minigene expression in knockin animals. Mice were killed by 
cervical dislocation, and the cortex and hippocampus were isolated. Tissue 
specimens were homogenized in the presence of lysis buffer containing 1% 
3-[(3-cholamidopropyl)dimethylammonio]-1-propane-sulfonate, 10 μM 
pepstatin, 10 μM leupeptin, 0.52 μM aprotinin, and 200 μM PMSF in PBS 
and centrifuged at full speed for 15 minutes at 4°C. The protein concentra-
tion was determined by measuring the extinction with a standard photom-
eter using the Warburg-Christian equation: (1.55 × A280) – (0.76 × A260). 
Protein (8 μg) from each sample was supplemented with 5× SDS sample 
buffer containing 50% glycerol, 3.5% SDS, 15% β-mercaptoethanol, and 
0.02% bromphenol blue and boiled for 7 minutes at 95°C. Protein solutions 
were loaded on a 10% SDS gel and processed for Western blot analysis, as 
described in the Supplemental Methods.
Cell culture and transfection. HEK293 cells were grown on coverslips in cell cul-
ture dishes containing MEM supplemented with 10% FCS and 1% penicillin/
streptomycin and containing 30 mM D-glucose, 10 mM HEPES, 0.23 mM 
sodium-pyruvate, and 0.25 mM L-glutamine. For transient protein expres-
sion, a standard Ca2+-phosphate protocol was applied, and cells were analyzed 
2 days after transfection. Primary hippocampal neurons from E19 Wistar rats 
were prepared as described (66) and kept in B27- and 1% FCS-supplemented 
neurobasal medium (67). The initial cell density was 68,000/cm2. Transfection 
was performed on day in vitro (div) 6 in the presence of transfection medium 
(neurobasal medium supplemented only with 0.25 mM glutamine) by incu-
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bating cells with complexes formed between 300 ng of DNA and 5 μl of Effec-
tene transfection reagent (QIAGEN). For cotransfection, a 1:1 ratio of the dif-
ferent DNAs was applied. The QIAGEN protocol was followed, except that the 
incubation time was reduced to 60 minutes, which ensured moderate protein 
expression in approximately 1% of the hippocampal neurons on div 9. Primary 
hippocampal neurons were also isolated from HA-GlyR α3L185L–targeted mice 
on postnatal day 0 and treated likewise.
Antibodies. For electron microscopy, guinea pig anti-VGluT1 (1:100; Syn-
aptic Systems) and rat monoclonal anti-HA (clone 3F10, 2 μg/ml; Roche 
Applied Science) were used. For fluorescence microscopy, the rat monoclo-
nal anti-HA antibody (Roche Applied Science) was used at 4 μg/ml, and the 
guinea pig polyclonal anti-VGluT1 (Synaptic Systems) was used at a 1:600 
dilution. Furthermore, rabbit polyclonal anti–neurofilament-M antibody 
(1:500; Kamiya Biomedical Company), guinea pig polyclonal anti-MAP2 
antibody (1:200; Synaptic Systems), rabbit polyclonal anti-VIAAT antibody 
(1:300; Synaptic Systems), and mouse monoclonal anti-parvalbumin anti-
body (clone 235, 1:2,500; Swant) were used. Secondary antibodies were pur-
chased from Jackson ImmunoResearch Laboratories and coupled to FITC, 
indocarbocyanin (Cy3), carboxymethyl indocyanine (Cy5), or aminometh-
ylcoumarin-acetat (AMCA). For Western blot analysis, rabbit polyclonal 
anti-tubulin antibody (1:1,000; Cell Signaling Technology), rat monoclo-
nal anti-HA antibody (clone 3F10, 0.1 μg/ml; Roche Applied Science), and 
mouse monoclonal SEC8 antibody (clone 14G1, 1:1,000; Abcam) were used. 
Secondary HRP- or alkaline phosphatase–coupled antibodies were used 
at the indicated dilution and purchased from Jackson ImmunoResearch 
Laboratories (1:10,000) or from Sigma-Aldrich (1:3,000).
Immunochemistry. Transfected HEK293 cells and neurons were fixed 
with an ice-cold mixture of PFA and sucrose (4% of each) for 15 minutes at 
room temperature. After three wash steps in PBS, the coverslips were pro-
cessed for immunochemistry using the antibodies mentioned above and as 
described previously (27, 68) and were then mounted on microscopy slides 
using VECTASHIELD medium with DAPI (Vector Laboratories). When 
quadruple staining (HA-α3L185L, SEC8::EGFP, neurofilament-M, and 
VGluT1) was performed, VECTASHIELD medium without DAPI was used.
For immunohistochemical analyses of GlyR HA-α3L185L expression in 
Hprtα3L185L+/0;PvalbCre+/– hippocampus, brain tissues from three male mice 
were isolated and fixed in a mixture of methanol and glacial acetic acid 
(95:5) for 30 minutes at –20°C. After three wash steps with PBS, cryopro-
tection was performed overnight at 4°C in PBS containing 8% sucrose. On 
the following day, tissues were embedded in Tissue-Tek O.C.T. Compound 
(Sakura Finetek), and 20-μm-thick cryosections (CM1850; Leica Microsys-
tems) were mounted on Superfrost microscope slides (Carl Roth). After 
fixation (5 minutes at –20°C with methanol-glacial acetic acid) of the fro-
zen cryosections, samples were blocked for 2 hours in PBS-gelatin. Primary 
antibodies were incubated overnight at 4°C in PBS-gelatin, and after three 
wash steps, secondary antibodies were incubated for 1 hour at room tem-
perature. After two wash steps in PBS-gelatin and one in PBS, samples were 
mounted in VECTASHIELD medium.
Microscopy. Transfected cells were visualized with a standard epifluo-
rescence microscope (BX51; Olympus) under a U Plan Apo ×40 oil objec-
tive with a numerical aperture of 1.00. Appropriate filters (U-MSP100v2 
MFISH DAPI, U-MSP101v1 MFISH FITC, U-MSP102v1 MFISH Cy3, and 
U-MSP104v1 MFISH Cy5) allowed the detection and separation of fluo-
rescent signals. Images were acquired using a 14-bit cooled CCD camera 
(Spot PURSUIT; Visitron Systems) and processed with Metamorph soft-
ware (Universal Imaging Corporation). Colocalization of GlyR α3K- and 
L-loops with SEC8::EGFP in HEK293 cells was quantified using line scans 
(10-μm length) and signal correlation analysis, as previously described (68). 
For quantification of nuclear versus somatic protein distributions, inte-
grated signal intensities were measured cell-wise within circular regions 
of interest (5 μm in diameter) that were nucleus centered and placed in 
the perinuclear cytoplasm. Neuronal subcellular distribution of full-length 
GlyR HA-α3L in transfected primary hippocampal neurons was quantified 
cell-wise using line scans (10 μm in length) of fluorescence intensities in 
soma as well as in proximal axonal and dendritic compartments (at dis-
tances from the soma of <100 μm and <50 μm, respectively). Hippocampal 
slice preparations from animals with targeted GlyR α3L185L expression 
were analyzed with confocal laser scanning microscopy (DM TCS SP5; 
Leica Microsystems), image deconvolution, and 3D reconstruction using 
Huygens professional image deconvolution software (Scientific Volume 
Imaging) and Imaris 7.6 software (Bitplane AG), respectively. Colocaliza-
tion of GlyR HA-α3L185L and parvalbumin or VIAAT was quantified using 
Pearson’s correlation and Manders’ overlap coefficients.
Pre-embedding double immunochemistry for electron microscopy. Immuno-
histochemical labeling for electron microscopy was performed as described 
earlier (69). Three- to 5-month-old male Hprtα3L185L+/0;Camk2aCre+/– 
mice (n = 4) with Camk2aCre-dependent expression of HA-tagged GlyR 
α3L185L and control Hprtα3L185L+/0 animals (n = 2) were used. Animals were 
deeply anesthetized with Narkodorm-n (180 mg/kg i.p.; Alvetra), and the 
hearts were surgically exposed for perfusion fixation. First, the vascular 
system was flushed by circulating 0.9% saline for 1 minute. This was fol-
lowed by transcardial perfusion with a fixative prepared in 0.1 M PBS 
(pH 7.4) containing 4% PFA (Merck), 15% saturated picric acid, and 0.05% 
glutaraldehyde (Polyscience). After perfusion, brains were removed from 
the skull, and tissue blocks containing the hippocampus were dissected 
and washed in 0.1 M PBS. Then, they were cryoprotected and freeze-
thawed, and 40-μm sections were cut. Sections were incubated in a block-
ing solution containing 20% normal goat serum (Vector Laboratories) 
prepared in 50 mM Tris-buffered saline (pH 7.3) for 1 hour, followed by 
overnight incubation at 4°C with a mixture of rat anti-HA and guinea pig 
anti-VGluT1 antibodies in 50 mM Tris-buffered saline containing 3% nor-
mal goat serum. After washing, the sections were transferred into a mixture 
of the following secondary antibodies: biotinylated goat anti-rat antibody 
(1:50; Vector Laboratories) and goat anti–guinea pig antibody (Fab fragment, 
1:100 Nanogold; Nanoprobes) coupled to 1.4 nm gold particle for quanti-
fication of the percentage of HA-positive glutamatergic synapses; or bioti-
nylated goat anti–guinea pig antibody (1:50; Vector Laboratories) and goat 
anti-rat antibody (Fab fragment, 1:100; Nanoprobes) coupled to 1.4 nm gold 
particle for visualization of the membrane topology of HA-GlyR α3L185L. 
After washing, sections were first reacted with HQ Silver kit (Nanoprobes) 
and then with avidin-biotin peroxidase complex (ABC kit; Vector Laborato-
ries) for 2 hours at room temperature. Subsequently, sections were incubated 
in 50 mM Tris-buffer (pH 7.3) containing 0.05% DAB tetrahydrochloride 
(Sigma-Aldrich) and 0.01% hydrogen peroxide. After treatment with OsO4, 
sections were stained with uranyl acetate, dehydrated, and flat embedded in 
Durcupan resin (Fluka). Ultrathin sections were prepared (Reichert-Nissei 
Ultracut S; Leica) for examination with a LEO 906 E electron microscope 
(Zeiss). The percentage of double-labeled (VGluT1/HA), GlyR α3L185L–posi-
tive (HA), VGluT1-positive, and nonlabeled boutons was determined and 
expressed as percentage fractions.
Whole-cell recording of paired-pulse responses. Hprtα3L185L+/0 control and 
Hprtα3L185L+/0;Camk2aCre+/– mice were anesthetized between postnatal days 
15 and 18 with halothane (5%) and decapitated. The brain was quickly 
removed and placed in an ice-cold dissection solution with a reduced calci-
um concentration consisting of: 125 mM NaCl, 4 mM KCl, 10 mM glucose, 
1.25 mM NaH2PO4, 25 mM NaHCO3, 0.1 mM CaCl2, and 3.0 mM MgCl2 
(pH 7.3). Transversal slices (200 μm) were prepared using a vibratome 
(Leica VT1000S; Leica Microsystems). Slices were maintained for at least 
1 hour at room temperature before recording. Whole-cell patch-clamp 
recordings were performed from CA1 pyramidal neurons visualized using 
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Recording of gamma-type network oscillatory activity. Experiments were per-
formed using hippocampal slices from 3- to 5-month-old Hprtα3L185L+/0, 
Hprtα3L185L+/0;PvalbCre+/–, and Hprtα3L185L+/0;Camk2aCre+/– animals. Transverse 
slices (400-μm-thick) were obtained as described earlier (70). The slices 
were transferred to an interface chamber continuously perfused with 
prewarmed (34°C), oxygenated (95% O2 and 5% CO2) ACSF containing 
126 mM NaCl, 3 mM KCl, 1.25 mM NaH2PO4, 2 mM CaCl2, 2 mM MgSO4, 
24 mM NaHCO3, and 10 mM glucose. Prior to recordings, the slices were 
allowed to rest for at least 1 hour after preparation. Kainate (400 nM) was 
applied by bath in order to elicit network oscillatory activity in the high-
frequency range (>30 Hz, denoted as gamma). To directly compare the 
hippocampal network activity of control Hprtα3L185L+/0 animals and mice 
with targeted GlyR protein expression, slices from the different animal 
groups were simultaneously recorded. Extracellular field potentials were 
acquired as described earlier (70). Briefly, recordings were done in the stra-
tum radiatum and pyramidale of areas CA1 and CA3 using glass pipettes, 
and they were low-pass-filtered at 1 kHz with a custom-made Bessel filter, 
digitized at 10 kHz using a Digidata 1322 (Axon Instruments), and ana-
lyzed using pClamp software (Axon Instruments). For determination of 
ripple oscillatory activity, traces were band-pass filtered (high-pass 8-pole 
Butterworth and low-pass 8-pole Bessel). The power spectra were calcu-
lated by Fourier transformation.
Classification of kainate-induced epileptic seizures in vivo. Three- to 5-month-
old male mice (five Hprtα3L185L+/0;Camk2aCre+/– mice and four Hprtα3L185L+/0 
control mice) received an i.p. injection of kainate (20 mg/kg BW; Tocris) 
dissolved in 0.9% saline. The experimenter was blinded to the genotype of 
the animals. After injection, mice were continuously observed for 2 hours, 
and seizure severity was classified according to Racine’s scale (71): stage 
0, normal behavior; stage 1, chewing and facial movements; stage 2, head 
nodding; stage 3, forelimb clonus; stage 4, rearing; stage 5, rearing, falling, 
and loss of posture. The seizure score was determined every 10 minutes, 
and the highest score reached during each 10-minute interval was used to 
calculate mean seizure severity scores for both groups of mice.
Analysis of LTP and LTD. Recordings were performed as described previ-
ously (72). Briefly, mice were decapitated, the hippocampus was removed, 
and 350-μm-thick slices were prepared using a vibroslicer. Slices were then 
incubated for 1.5 hours at 33°C ± 1°C in oxygenated (95% O2 and 5% CO2) 
ACSF containing 124 mM NaCl, 2 mM KCl, 26 mM NaHCO3, 1.24 mM 
KH2PO4, 2.5 mM CaCl2, 2 mM MgSO4, and 10 mM glucose (pH 7.4) in 
a standard interface chamber. Recordings were made with a glass pipette 
containing 0.75 M NaCl (4 MΩ) that was placed in the stratum radiatum of 
CA1. Stimulation was evoked using a Master-8 pulse stimulator (A.M.P.I.) 
and delivered through a set of bipolar nichrome electrodes placed on 
the side of the recording electrode. LTP was induced by high-frequency 
(100 Hz) stimulation consisting of 100 pulses at twice the current that 
elicited 50% of the maximal response. LTD was induced by applying low-
frequency (1 Hz) stimulation (900 pulses). Baseline values were recorded at 
a frequency of 0.033 Hz. Responses were digitized at 5 kHz and stored on 
a computer. Off-line analysis and data acquisition were performed using 
Spike 2 software (Cambridge Electronic Design). Changes in the slope 
of EPSPs following Schaffer collateral stimulation were calculated with 
respect to baseline and followed for at least 45 minutes.
Behavior analyses. All behavioral tests were performed by an experimenter 
who was blinded to the genotype of the animals. All details on the indi-
vidual tests are provided in the Supplemental Methods.
Statistics. One-way ANOVA analysis followed by a post-hoc Bonfer-
roni’s test were used for statistical analysis of fluorescence in transfected 
HEK293 cells. Two-way ANOVA followed by a post-hoc Bonferroni’s test 
were used for statistical analysis of fluorescence in transfected primary 
neurons. Data obtained from analyses of animal behavior were tested for 
a Zeiss upright microscope fitted with a ×63 water immersion objective. 
Slices were transferred to a recording chamber and continuously perfused 
(1–1.5 ml/minute) with  a bath solution containing 125 mM NaCl, 4 mM 
KCl, 10 mM glucose, 1.25 mM NaH2PO4, 25 mM NaHCO3, 2.0 mM 
CaCl2, and 1.0 mM MgCl2 (pH 7.3) and bubbled at room temperature with 
95% O2 and 5% CO2. Excitatory postsynaptic currents (EPSCs) were iso-
lated pharmacologically by blocking GABAA and GABAB receptors as well 
as NMDA receptor–dependent currents (gabazine, 1 μM; 2-hydroxysa-
clofen, 100 μM; DL-2-amino-5-phosphonovaleric acid, 50 μM). 
To block glycinergic receptors including GlyR α3L185L activation in the 
nominal absence of glycine, a high dose of strychnine (10 μM) had to be 
applied. The patch pipette solution contained 120 mM CsCl, 4 mM NaCl, 
5 mM glucose, 5 mM EGTA, 10 mM HEPES, 0.5 mM CaCl2, and 4 mM 
MgCl2 (pH 7.3). Evoked EPSCs were induced by stimulation of the Schaf-
fer collateral pathway through a glass pipette filled with bath solution. 
Paired pulses (50-ms interstimulus intervals, every 30 seconds) of con-
stant current (2–7 μA, 0.5 ms) were delivered with an Analog Stimulus 
Isolator Model 2200 (A-M Systems). The stimulus intensity was adjusted 
to obtain a minimal, but clear, postsynaptic response. During recordings 
at a holding potential of –80 mV, the access resistance was in the range of 
6 to 15 MΩ, compensated up to 60%, and checked throughout the entire 
experiment by using a short depolarizing pulse. Recordings were accepted 
only if the access resistance was less than 15 MΩ and did not change by 
more than 20% during the experiment. Recordings were made with an 
EPC-10 (HEKA Electronics). Signals were acquired at a rate of 10 kHz and 
analyzed off-line using WinTida 5.0 (HEKA Electronics).
Recording of local field potentials. The experiments were performed on brain 
slices obtained from 3- to 12-month-old male Hprtα3L185L+/0, Hprtα3L185L+/0; 
Camk2aCre+/–, and Hprtα3L185L+/0;PvalbCre+/– mice. Animals were decapitated 
under N2O (70% N2O and 30% O2) and isoflurane (starting with 3% isoflu-
rane and then rapidly reducing it to 0.5%) anesthesia. Brains were placed 
in ice-cold oxygenated (95% O2 and 5% CO2) artificial cerebrospinal fluid 
(ACSF) that contained 129 mM NaCl, 21 mM NaHCO3, 3 mM KCl, 1.6 mM 
CaCl2, 1.8 mM MgSO4, 1.25 mM NaH2PO4, and 10 mM glucose at a pH of 
7.4 and an osmolarity of 300 ± 5 mOsm/kg. Horizontal hippocampal slices 
(400 μm at bregma –4.7 to –7.3 mm) were prepared at an angle of 12° in the 
fronto-occipital direction (with the frontal portion up) using a vibratome 
(752 M Vibroslice; Campden Instruments). Brain slices were transferred to 
an interface recording chamber continuously perfused with ACSF at a flow 
rate of 1.8 ± 0.2 ml/minute at 36°C ± 0.1°C. Slices were incubated for 1 to 
2 hours before the start of recording.
For analysis of network excitability, field potentials were recorded in area 
CA3 using microelectrodes filled with ACSF with resistances of 5 to 10 MΩ. 
To investigate whether the threshold to induce epileptiform discharge 
was altered in mice with GlyR α3L185L expression in glutamatergic prin-
cipal cells or parvalbumin-positive interneurons, competitive GABAAR 
antagonists were used. In the first set of experiments, 2.5 μM or 10 μM 
BIC was applied. In the second set of experiments, two different concentra-
tions of another competitive GABAAR antagonist, gabazine, were applied 
(0.3 μM and 3 μM). Signals were preamplified using a custom-made ampli-
fier equipped with negative capacitance regulation and low pass filtered 
at 3 kHz. Signals were sampled at a frequency of 10 kHz and stored on a 
computer hard disk for off-line analysis (Cambridge Electronic Design).
For analysis of glutamatergic transmission at the Schaffer collateral syn-
apse in Hprtα3L185L+/0;PvalbCre+/– mice, field potentials were recorded from 
the stratum radiatum of area CA1. A bipolar stimulation electrode was 
placed at the Schaffer collaterals proximal to the CA1, and 20–30 min-
utes later, when the responses had been stabilized, an input-output curve 
was obtained (interstimulus interval: 20 seconds). Stimulation intensities 
ranged from 10 to 50 μA, and signals were processed as described above.
Downloaded on February  4, 2014.   The Journal of Clinical Investigation.   More information at  www.jci.org/articles/view/71472
research article
710 The Journal of Clinical Investigation   http://www.jci.org   Volume 124   Number 2   February 2014
management of our mouse colonies, and genotyping. We thank 
Natalie Callies and Sigrun Nestel (University of Freiburg) for their 
assistance with molecular cloning and electron microscopy. We 
thank Stefan Müller (Center for Molecular Medicine Cologne) 
for performing peptide mass finger printing and Anje Sporbert 
(Joint Intravital Microscopy and Imaging platform [JIMI], Max 
Delbrück Center for Molecular Medicine) for support and access 
to the SP5 confocal microscope. This work was funded by the 
Helmholtz Association (VH-NG-246, to J.C. Meier); the Deutsche 
Forschungsgemeinschaft (DFG) (ME2075/3-1, to J.C. Meier; SFB-
TR3 B5, to J.C. Meier and T. Gloveli; SFB635 A11, to G. Schwarz; 
SFB780 C2, to C.A. Haas; SFB780 A2, to A. Kulik; BIOSS-2 A6, to 
A. Kulik; GL254/5-1 and GL254/5-2, to T. Gloveli; and Ra424/5-1, 
to F.G. Rathjen); the Center for Molecular Medicine Cologne (D5, 
to G. Schwarz); Fonds der Chemischen Industrie (to G. Schwarz); 
and the Bundesministerium für Bildung und Forschung (BMBF) 
(BCCN II A3, to T. Gloveli and ERA-Net NEURON II CIPRESS, to 
J.C. Meier and C.A. Haas).
Received for publication June 7, 2013, and accepted in revised 
form October 31, 2013.
 
Address correspondence to: Jochen C. Meier, Max Delbrück Center 
for Molecular Medicine, Robert-Rössle-Str. 10, 13092 Berlin, Ger-
many. Phone: 49.0.30.9406.3062; Fax: 49.0.30.9406.3819; E-mail: 
jochen.meier@mdc-berlin.de.
statistical significance using one- or two-way ANOVA as the case may be, 
followed by a post-hoc Bonferroni’s test. Statistical analysis of the means ± 
SEM obtained from LTP and LTD experiments was performed by applying 
one-way ANOVA analysis followed by a post-hoc Bonferroni’s test. Sigma-
Plot (Systat Software) and Origin software (Microcal) were used. Statistical 
analysis of field potential recordings and epileptiform network activity was 
performed with SigmaPlot. A One-tailed Student’s t test was used for sta-
tistical comparisons of the means ± SEM. Two-way ANOVA followed by a 
post-hoc Bonferroni’s test (GraphPad Prism 4.02 software) was applied for 
analysis of statistical significance between the means ± SEM in behavioral 
seizure experiments. Statistical analysis of the means ± SEM obtained from 
paired-pulse recordings was performed using SigmaPlot v11.0. A Mann-
Whitney U test was applied for statistical comparisons after testing the 
data for normality (Shapiro-Wilk test). A P value of less than 0.05 was con-
sidered significant. Significant differences are indicated in the Figures as 
*P < 0.05, **P < 0.01, and ***P < 0.001.
Study approval. Animals were handled according to regulations established 
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by the IACUC of the Office for Health Protection and Technical Safety of 
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O-0389/10) and the regional council of Freiburg (permit G-11/86).
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